These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 788079)

  • 1. Prevention of hyaline membrane disease with plasminogen. Preliminary report of a cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):195-8. PubMed ID: 788079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hyaline membrane disease with plasminogen. A cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP; Weintraub DH; Courey NG; Patterson RJ; Jockin H; Pickren JW; Bross ID; Jung OS; Ambrus JL
    JAMA; 1977 Apr; 237(17):1837-41. PubMed ID: 321823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Irwin ; Bross DJ; Jung OS; Mink IB; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):341-4. PubMed ID: 4582209
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.
    Ambrus JL; Ambrus CM
    J Med; 1990; 21(1-2):67-84. PubMed ID: 2145377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Am J Dis Child; 1974 Feb; 127(2):189-94. PubMed ID: 4589496
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the prevention of respiratory distress syndrome of infants due to hyaline membrane disease with plasminogen.
    Ambrus CM; Choi TS; Weintraub DH; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Semin Thromb Hemost; 1975 Jul; 2(1):42-51. PubMed ID: 798269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hyaline membrane disease with the plasminogen urokinase combination].
    Leroux B; Rose JP; Potron G; Grun G; Droulle C; Mesmin F; Gomes H
    Nouv Presse Med; 1976 Mar; 5(11):699-702. PubMed ID: 772595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.
    Kwong MS; Egan EA; Notter RH; Shapiro DL
    Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Variations of plasminogen in newborn and premature infants].
    Potron G; Leroux B; Bertignon C; Graftiaux A
    Arch Fr Pediatr; 1972; 29(6):583-92. PubMed ID: 4672950
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
    Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
    Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antenatal use of ambroxol (bromhexine metabolite VIII) to prevent hyaline membrane disease: a controlled double-blind study.
    Wauer RR; Schmalisch G; Menzel K; Schröder M; Müller K; Tiller R; Methfessel G; Sitka U; Koepke E; Plath C; Schlegel C; Böttcher M; Köppe I; Fricke U; Severin K; Jacobi R; Schmidt W; Hinkel GK; Nitz I; Kunze D; Reichmann G; Lachmann B; Lampe K; Grauel EL
    Int J Biol Res Pregnancy; 1982; 3(2):84-91. PubMed ID: 7042592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Betamethasone in the prevention of pulmonary hyaline membrane disease: the results and applicability of G.C. Liggins' protocol].
    Scarcella A; De Filippis A; Cascioli CF; Balletta M; Rossi E; Ciccimarra F
    Minerva Pediatr; 1983 Apr; 35(7):307-11. PubMed ID: 6346034
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC; Howie RN
    Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of respiratory distress in premature infants through pernatal treatment with betamethasone].
    Di Meglio L; Furbatto G; Gallo G; Vercellotti E
    Minerva Ginecol; 1979; 31(7-8):557-62. PubMed ID: 481813
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with preterm labor: use of ritodrine and betamethasone.
    Kwong MS; Egan EA
    Pediatrics; 1986 Nov; 78(5):767-74. PubMed ID: 3532016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of corticosteroids and fetomaternal disorders on the L:S ratio.
    Morrison JC; Schneider JM; Whybrew WD; Bucovaz ET
    Obstet Gynecol; 1980 Nov; 56(5):583-90. PubMed ID: 6893624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease).
    Sahu S
    J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
    Walti H; Relier JP; Huon C; Monset-Couchard M; Scemama M; De Gamarra E; Moriette G; Curstedt T; Robertson B
    Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hyaline membrane disease.
    Br Med J; 1973 Apr; 2(5858):65-6. PubMed ID: 4700320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.